Wellington Management Group
IMNM icon

Wellington Management Group’s Immunome IMNM Stock Holding History

Wellington Management Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110M Buy
5,210,216
+478,239
+10% +$10.2M 0.02% 527
2026
Q1 		$103M Buy
4,731,977
+3,797,514
+406% +$84.5M 0.02% 545
2025
Q4 		$20.1M Buy
934,463
+680,395
+268% +$11.9M ﹤0.01% 1030
2025
Q3 		$2.98M Buy
254,068
+42,239
+20% +$420K ﹤0.01% 1552
2025
Q2 		$1.97M Buy
211,829
+58,818
+38% +$482K ﹤0.01% 1584
2025
Q1 		$1.03M Buy
153,011
+7,447
+5% +$71.4K ﹤0.01% 1703
2024
Q4 		$1.55M Buy
145,564
+4,874
+3% +$58.9K ﹤0.01% 1635
2024
Q3 		$2.06M Buy
140,690
+81,354
+137% +$1.16M ﹤0.01% 1534
2024
Q2 		$718K Buy
59,336
+4,587
+8% +$71.8K ﹤0.01% 1734
2024
Q1 		$1.35M Buy
+54,749
New +$1.11M ﹤0.01% 1615

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group's IMNM Position: Q2 2026 in Review

Wellington Management Group increased its Immunome (IMNM) stake by 10% in Q2 2026, buying an estimated $10.2M and bringing the position to 5,210,216 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #527.

Wellington Management Group first reported a position in IMNM in Q1 2024 and has held it in 10 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Wellington Management Group held 5,210,216 shares of Immunome worth $110M as of Q2 2026.
  • Wellington Management Group bought 478,239 Immunome shares in Q2 2026, an estimated $10.2M.
  • Immunome made up 0.02% of Wellington Management Group's portfolio in Q2 2026, its #527 holding.
  • Wellington Management Group first reported a position in Immunome in Q1 2024 and has held it in 10 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.